I don't think they would buy it out right, more likely they would enter into a phase 3 trial funding deal with milestone payments for exclusive US commercial licensing rights.
But that in itself could be worth over $1b USD... and would push the share price up considerably.
So we await the DME results, as you say I don't think timing will have been unduly affected by Covid-19 restrictions.
I don't think they would buy it out right, more likely they...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $695.5M | |||
| Open | High | Low | Value | Volume |
| 57.5¢ | 57.5¢ | 55.0¢ | $706.9K | 1.260M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 79437 | 55.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 174437 | 2 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| OPT (ASX) Chart |